Ed Mascioli, MD

Prior to Peptimmune, he was at MPM Capital, a leading healthcare venture capital firm. While at MPM, he served on the boards of Arriva Pharmaceuticals, CGI Pharmaceuticals, Elixir Pharmaceuticals, Mindset, Oxagen, Peptimmune and Radius Health. Ed's entrepreneurial experience includes founding, funding, and operating a successful outpatient medical services company for two years. He holds two licensed patents for marketed products, has received the Baxter Healthcare Corporation Award, and has authored several dozen scientific publications. For several years, he co-directed an annual Harvard Medical School Continuing Medical Education Course on Obesity Therapy. Ed holds an MS from MIT, an MD from the University of Massachusetts Medical School, and a BA, cum laude, from Brandeis University. He has also participated in a Harvard Business School course on Strategic Negotiation.